Here, we examined the effectiveness of treatments with RP81 and a more soluble related-renalase peptide, RP10 (Fig. 1A), given systemically in murine models of post-ERCP pancreatitis (PEP) and severe cerulein acute pancreatitis to reduce injury. The gene discussed is RNLS; the disease is pancreatitis.